Association between non-enzymatic glycation, resorption, and microdamage in human tibial cortices

Osteoporosis International

Volumn 26, Issue 3, 2015, Pages 865-873

  Ural, A ^a   Janeiro, C ^b   Karim, L ^b,c   Diab, T ^b   Vashishth, D ^b  

^a Villanova University   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Advanced glycation end products; Bone resorption; Cortical bone; Microdamage; Non enzymatic glycation

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGE; AGED; ARTICLE; BONE; BONE DENSITY; BONE FRAGILITY; BONE INJURY; BONE REMODELING; CORTICAL BONE; DONOR; FEMALE; FLUORESCENCE; GLYCATION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PRIORITY JOURNAL; TIBIA; AGING; INJURIES; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AGING; BONE RESORPTION; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; TIBIA; YOUNG ADULT;

EID: 84925538057     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2938-4     Document Type: Article

References (46)

1. Seeman E, Delmas PD (2006) Bone quality—the material and structural basis of bone strength and fragility. N Engl J Med 354(21):2250–2261
2. Hui SL, Slemenda CW, Johnston CC Jr (1988) Age and bone mass as predictors of fracture in a prospective study. J Clin Investig 81(6):1804–1809
3. Vashishth D (2005) Age-dependent biomechanical modifications in bone. Crit Rev Eukaryot Gene Expr 15(4):343–358
4. Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28(2):195–201
5. Wang X, Shen X, Li X, Mauli Agrawal C (2002) Age-related changes in the collagen network and toughness of bone. Bone 31(1):1–7
6. McCarthy AD, Etcheverry SB, Cortizo AM (1999) Advanced glycation endproduct-specific receptors in rat and mouse osteoblast-like cells: Regulation with stages of differentiation. Acta Diabetol 36(1):45–52
7. Dong XN, Qin A, Xu J, Wang X (2011) In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption. Bone 49(2):174–183
8. Miyata T, Notoya K, Yoshida K, Horie K, Maeda K, Kurokawa K, Taketomi S (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 8(2):260–270
9. Valcourt U, Merle B, Gineyts E, Viguet-Carrin S, Delmas PD, Garnero P (2007) Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 282(8):5691–5703
10. Tang SY, Vashishth D (2010) Non-enzymatic glycation alters microdamage formation in human cancellous bone. Bone 46(1):148–154
11. Tang SY, Zeenath U, Vashishth D (2007) Effects of non-enzymatic glycation on cancellous bone fragility. Bone 40(4):1144–1151
12. Bentolila V, Boyce TM, Fyhrie DP, Drumb R, Skerry TM, Schaffler MB (1998) Intracortical remodeling in adult rat long bones after fatigue loading. Bone 23(3):275–281
13. Herman BC, Cardoso L, Majeska RJ, Jepsen KJ, Schaffler MB (2010) Activation of bone remodeling after fatigue: Differential response to linear microcracks and diffuse damage. Bone 47(4):766–772
14. Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15(4):613–620
15. Diab T, Vashishth D (2007) Morphology, localization and accumulation of in vivo microdamage in human cortical bone. Bone 40(3):612–618
16. Poundarik AA, Diab T, Sroga GE, Ural A, Boskey AL, Gundberg CM, Vashishth D (2012) Dilatational band formation in bone. Proc Natl Acad Sci 109(47):19178–19183
17. Karim L, Vashishth D (2012) Heterogeneous glycation of cancellous bone and its association with bone quality and fragility. PLoS One 7(4):e35047
18. Gross J (1958) Studies on the formation of collagen. I. Properties and fractionation of neutral salt extracts of normal guinea pig connective tissue. J Exp Med 107(2):247–263
19. Burr DB, Stafford T (1990) Validity of the bulk-staining technique to separate artifactual from in vivo bone microdamage. Clin Orthop Relat Res 260:305–308
20. Boyce TM, Fyhrie DP, Glotkowski MC, Radin EL, Schaffler MB (1998) Damage type and strain mode associations in human compact bone bending fatigue. J Orthop Res 16(3):322–329
21. Tang S, Allen M, Phipps R, Burr D, Vashishth D (2009) Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int 20(6):887–894
22. Yamagishi S-i (2011) Role of Advanced Glycation End Products (AGEs) in osteoporosis in diabetes. Curr Drug Targets 12(14):2096–2102
23. Semba RD, Nicklett EJ, Ferrucci L (2010) Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A: Biol Med Sci 65A(9):963–975
24. Weinberg E, Maymon T, Weinreb M (2014) AGEs induce caspase-mediated apoptosis of rat BMSCs via TNFα production and oxidative stress. J Mol Endocrinol 52(1):67–76
25. Hein GE (2006) Glycation endproducts in osteoporosis—Is there a pathophysiologic importance? Clin Chim Acta 371(1–2):32–36
26. Saito M, Marumo K, Soshi S, Kida Y, Ushiku C, Shinohara A (2010) Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. Osteoporos Int 21(4):655–666
27. Hein G, Weiss C, Lehmann G, Niwa T, Stein G, Franke S (2006) Advanced glycation end product modification of bone proteins and bone remodelling: Hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 65(1):101–104
28. Hein G, Wiegand R, Lehmann G, Stein G, Franke S (2003) Advanced glycation end-products pentosidine and Nϵ-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology 42(10):1242–1246
29. Franke S, Siggelkow H, Wolf G, Hein G (2007) Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts. Arch Physiol Biochem 113(3):154–161
30. Ding K-H, Wang Z-Z, Hamrick MW, Deng Z-B, Zhou L, Kang B, Yan S-L, She J-X, Stern DM, Isales CM, Mi Q-S (2006) Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. Biochem Biophys Res Commun 340(4):1091–1097
31. Fatayerji D, Eastell R (1999) Age-related changes in bone turnover in men. J Bone Miner Res 14(7):1203–1210
32. Minisola S, Dionisi S, Pacitti MT, Paglia F, Carnevale V, Scillitani A, Mazzaferro S, De Geronimo S, Pepe J, D’Erasmo E, Romagnoli E (2002) Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone. Osteoporos Int 13(2):171–175
33. Rehman MTA, Hoyland JA, Denton J, Freemont AJ (1994) Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 47(6):529–534
34. Wishart JM, Need AO, Horowitz M, Morris HA, Nordin BEC (1995) Effect of age on bone density and bone turnover in men. Clin Endocrinol 42(2):141–146
35. Martin RB, Pickett JC, Zinaich S (1980) Studies of skeletal remodeling in aging men. Clin Orthop Relat Res 149:268–282
36. Cooper DML, Thomas CDL, Clement JG, Hallgrímsson B (2006) Three-dimensional microcomputed tomography imaging of basic multicellular unit-related resorption spaces in human cortical bone. Anat Rec A: Discov Mol Cell Evol Biol 288A(7):806–816
37. Bernhard A, Milovanovic P, Zimmermann EA, Hahn M, Djonic D, Krause M, Breer S, Püschel K, Djuric M, Amling M, Busse B (2013) Micro-morphological properties of osteons reveal changes in cortical bone stability during aging, osteoporosis, and bisphosphonate treatment in women. Osteoporos Int 24(10):2671–2680
38. Ural A, Vashishth D (2006) Interactions between microstructural and geometrical adaptation in human cortical bone. J Orthop Res 24(7):1489–1498
39. Qiu S, Rao DS, Palnitkar S, Parfitt AM (2010) Dependence of bone yield (volume of bone formed per unit of cement surface area) on resorption cavity size during osteonal remodeling in human rib: implications for osteoblast function and the pathogenesis of age-related bone loss. J Bone Miner Res 25(2):423–430
40. Vashishth D, Koontz J, Qiu SJ, Lundin-Cannon D, Yeni YN, Schaffler MB, Fyhrie DP (2000) In vivo diffuse damage in human vertebral trabecular bone. Bone 26(2):147–152
41. Karim L, Tang S, Sroga G, Vashishth D (2013) Differences in non-enzymatic glycation and collagen crosslinks between human cortical and cancellous bone. Osteoporos Int 24(9):2441–2447
42. Odetti P, Rossi S, Monacelli F, Poggi A, Cirnigliaro M, Federici M, Federici A (2005) Advanced glycation end products and bone loss during aging. Ann N Y Acad Sci 1043(1):710–717
43. Diab T, Condon KW, Burr DB, Vashishth D (2006) Age-related change in the damage morphology of human cortical bone and its role in bone fragility. Bone 38(3):427–431
44. Schaffler MB, Choi K, Milgrom C (1995) Aging and matrix microdamage accumulation in human compact bone. Bone 17(6):521–525
45. Norman TL, Wang Z (1997) Microdamage of human cortical bone: Incidence and morphology in long bones. Bone 20(4):375–379
46. Arlot ME, Burt-Pichat B, Roux J-P, Vashishth D, Bouxsein ML, Delmas PD (2008) Microarchitecture influences microdamage accumulation in human vertebral trabecular bone. J Bone Miner Res 23(10):1613–1618